Lingli Huang - Publications

Efficacy and Safety of Different Sequences for mFOLFIRINOX (or SOXIRI) and Gemcitabine Plus Albumin-Bound Paclitaxel in Unresectable Pancreatic Cancer.

Journal: ImmunoTargets and therapy

Published: April 24, 2025

Comprehensive analysis of the functional and immunological significance of ETV4 in pan-cancer and its validation in digestive tumors.

Journal: Frontiers in immunology

Published: March 18, 2025

EBV enhances immunotherapy sensitivity in intrahepatic cholangiocarcinoma through cGAS-STING pathway activation.

Journal: Hepatology communications

Published: December 07, 2024

Predictive significance of MPT-driven necrosis-related genes signature in gastric cancer and their impact on the tumor microenvironment.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 21, 2024

What is the truth: the roles of macrophages in EBV-LELCC.

Journal: Hepatology international

Published: September 03, 2024

A commentary on 'Complex causal association between genetically predicted 731 immunocyte phenotype and osteonecrosis: a bidirectional two-sample Mendelian randomization analysis'.

Journal: International journal of surgery (London, England)

Published: March 30, 2024

Anatomical classification of advanced biliary tract cancer predicts programmed cell death protein 1 blockade efficacy.

Journal: Frontiers in pharmacology

Published: January 29, 2024

Comment on "Psoriasis may increase the risk of lung cancer: A two-sample Mendelian randomization study".

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 31, 2023

Deciphering the causal association and co-disease mechanisms between psoriasis and breast cancer.

Journal: Frontiers in immunology

Published: September 30, 2023

Stigma and its correlates among patients with Crohn's disease: A cross-sectional study in China.

Journal: International journal of nursing sciences

Published: February 25, 2023

Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer.

Journal: Therapeutic advances in medical oncology

Published: December 16, 2022

Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.

Journal: Cancer medicine

Published: November 30, 2022